Gene · 2203
Papers2,174
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,174
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy. | Exp Hematol Oncol | 2023 | 36998063 | PubTator, text mining | PubMed |
| Identification and Characterization of Metabolic Subtypes of Endometrial Cancer Using a Systems-Level Approach. | Metabolites | 2023 | 36984849 | PubTator, text mining | PubMed |
| Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5. | Metabolites | 2023 | 36984771 | PubTator, text mining | PubMed |
| Integrative Analysis of Blood Transcriptomics and Metabolomics Reveals Molecular Regulation of Backfat Thickness in Qinchuan Cattle. | Animals (Basel) | 2023 | 36978600 | PubTator, text mining | PubMed |
| Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis. | BMC Med Genomics | 2023 | 36978098 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 | 36973268 | PubTator, text mining | PubMed |
| Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II. | Front Oncol | 2023 | 36968996 | PubTator, text mining | PubMed |
| HDAC2 as a target for developing anti-cancer drugs. | Comput Struct Biotechnol J | 2023 | 36968022 | PubTator, text mining | PubMed |
| SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma. | BMC Urol | 2023 | 36959648 | PubTator, text mining | PubMed |
| Metagenomic Discovery of "Candidatus Parvarchaeales"-Related Lineages Sheds Light on Adaptation and Diversification from Neutral-Thermal to Acidic-Mesothermal Environments. | mSystems | 2023 | 36943058 | PubTator, text mining | PubMed |
| Deep thermal profiling for detection of functional proteoform groups. | Nat Chem Biol | 2023 | 36941476 | PubTator, text mining | PubMed |
| Editorial: Double-edged swords: Important factors connecting metabolic disorders and cancer development - from basic research to translational applications. | Front Endocrinol (Lausanne) | 2023 | 36936168 | PubTator, text mining | PubMed |
| Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 36923478 | PubTator, text mining | PubMed |
| CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect. | J Exp Clin Cancer Res | 2023 | 36922872 | PubTator, text mining | PubMed |
| mir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes. | J Cell Commun Signal | 2023 | 36917438 | PubTator, text mining | PubMed |
| Down-regulation of FBP1 in lung adenocarcinoma cells promotes proliferation and invasion through SLUG mediated epithelial mesenchymal transformation. | Transl Cancer Res | 2023 | 36915593 | PubTator, text mining | PubMed |
| Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys. | Nat Commun | 2023 | 36906645 | PubTator, text mining | PubMed |
| GBE1 Promotes Glioma Progression by Enhancing Aerobic Glycolysis through Inhibition of FBP1. | Cancers (Basel) | 2023 | 36900384 | PubTator, text mining | PubMed |
| Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer. | Cancers (Basel) | 2023 | 36900361 | PubTator, text mining | PubMed |
| Transcriptional Response to Hypoxia: The Role of HIF-1-Associated Co-Regulators. | Cells | 2023 | 36899934 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2203/papers?page=17